Antimicrobial resistance (AMR) arises when micro-organisms survive exposure to a drug that would normally kill them or stop their growth. Antibiotic resistance (ABR) specifically is resistance to antibiotics that occurs in bacteria. It is globally recognized as an emerging public-health threat as antibiotics are becoming increasingly ineffective against diseasecausing bacteria. ABR can lead to greater spread of infectious diseases, difficulty in treating common infections, uncertainty in success of high-end procedures, longer hospital stays and more expensive treatments. By 2050, AMR is estimated to lead to 10 million deaths per year and lost outputs worth US $100 trillion across the world.